查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827709

2025年心臟节律器全球市场报告

Cardiac Pacemakers Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，心臟节律器市场稳定成长，预计2024年将达到47.3亿美元，2025年将达到49.5亿美元，复合年增长率为4.6%。预测期内的成长动力包括人口老化、心血管疾病发生率上升、人们对心律不整的认识和治疗需求不断增强、起搏器创新研发投入不断增加、医疗基础设施不断发展和医疗设备可及性不断提升，以及监管机构对起搏器新功能和技术的核准。

预计未来几年心臟节律器市场将强劲成长，到 2029 年将达到 65 亿美元，复合年增长率为 7.1%。预测期内的成长归因于对导线耐用性和减少併发症的关注、为起搏器患者提供的远端程式设计和远端医疗服务、新兴市场的扩张和不断上涨的医疗成本、增强的电池技术以延长起搏器使用寿命，以及加快起搏器核准的监管支援。预测期内的主要趋势包括精准植入的电生理学进步、起搏器数据与电子健康记录(EHR) 的整合、人工智慧 (AI) 的整合以进行预测性起搏器维护、起搏器技术进步（包括小型化）以及远距远端医疗和远端监控。

心臟节律器是一种小型电子设备，它能产生电脉衝来调节心率，并治疗心律不整等疾病。这些设备在防止心跳过快或过慢方面发挥着至关重要的作用。

心臟节律器主要分为植入式和外置式。植入式心臟节律器是透过手术植入胸腔的电子设备，可产生电脉衝来调节心率。各种心臟节律器技术包括双心室、单心室和双心室系统。这些设备用于治疗各种疾病，包括心律不整、心臟传导阻滞、心房颤动、长QT症候群和郁血性心臟衰竭。心臟节律器可供最终使用者使用，包括诊所、医院、门诊手术中心和心臟护理中心。随着技术和外科手术的不断进步，市场也在不断发展，有助于改善患者照护和治疗效果。

2025年春季美国关税大幅上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供心臟起搏器市场统计数据，包括全球市场规模、区域份额、心臟起搏器市场份额竞争对手、详细的心臟起搏器细分市场、市场趋势和商业机会，以及在心臟起搏器行业取得成功所需的数据。这份心臟起搏器市场研究报告提供了全面的展望，并对产业现状和未来进行了详细分析。

未来五年7.1%的预测成长率较我们先前对该市场的预测略有下降，下降幅度为0.1%。下降的主要原因是美国与其他国家之间的关税影响。这种影响可能会直接影响到美国，导致锂碘电池电芯和密封钛外壳的供应链中断，这些电池主要来自中国和墨西哥等主要地区，这可能导致植入手术延误，并增加心搏过缓治疗的成本。

心血管疾病的快速成长是心臟节律器市场的主要驱动力。心血管疾病包括影响心臟和血管的各种疾病，例如心律不整、主动脉疾病、先天性心臟疾病和心臟病发作。为了解决这个日益严重的全球健康问题，人们开始采用产生电活动的心臟节律器来治疗心血管疾病患者。世界卫生组织 (WHO) 于 2023 年 9 月报告称，心血管疾病每年将导致 4,100 万人死亡，占非传染性疾病的 74%，凸显了对心臟治疗进步的迫切需求。因此，心血管疾病盛行率的不断上升预计将推动心臟起搏器市场的成长。

政府旨在促进医疗保健研究和开发的倡议有望推动心臟起搏器市场的发展。各级政府部门采取的这些倡议包括旨在应对医疗保健挑战和促进社会积极变革的行动、计划和政策。值得注意的是，2022 年，英国政府拨款 2.6 亿英镑（2.7065 亿美元）用于加强医疗保健研究和製造。卫生和社会保障部的这项承诺着重于加强临床研究服务，并支持 NHS主导的诊断​​和治疗方法健康研究。此外，还拨款 6,000 万英镑（6,360 万美元）用于扩大英国的生命科学製造业。这些政府倡议在推动心臟治疗和推动心臟起搏器市场成长方面发挥关键作用。

技术创新，尤其是无导线心律调节器的发展，是心臟节律器市场的关键趋势。主要企业正在积极推出创新解决方案，以加强患者照护和市场竞争力。无导线起搏器是自足式的发电机和电极系统，其显着优势在于：比传统的经静脉起搏器体积小90%。透过股静脉经导管技术植入，无需胸部切口或皮下发电机袋。值得注意的是，2022年1月，总部位于爱尔兰的医疗设备製造商Medtronic力公司推出了Micra AV经导管起搏系统（TPS），这是一款专为心室和心房之间电传导受损的患者设计的无导线起搏器。

心臟起搏器市场的主要企业正在透过 i2i（设备间）通讯技术等产品进行创新，该技术促进了两个设备之间的即时通讯。这种 i2i（设备间）通讯技术可实现不同基础设施系统之间的无缝资料交换，从而提高自动化程度和营运效率。例如，2023 年 11 月，美国医疗设备製造商雅培实验室推出了 AVEIR DR 系统，用于治疗心律不整或延迟的患者。此尖端的双腔无导线心律调节器系统可为右心房和心室提供同步起搏，确保正常的心律。它透过微创手术植入，减少了恢復时间和併发症。先进的设备植入技术可实现设备之间的即时通讯，协调有效的起搏。这项技术创新代表了心臟健康管理的重大进步。

2022年7月，专注于变革性治疗产品的美国公司Orchestra BioMed与Medtronic合作。Medtronic与Orchestra BioMed的合作旨在开发Backbeat心臟神经调节疗法（CNT），这是一种潜在的治疗高血压的方案，适用于需要安装心臟起搏器的人。此次合作彰显了Medtronic等领先公司致力于开拓医疗技术进步、促进心臟护理发展的承诺。

心臟起搏器市场的一些主要企业包括美敦力公司、乐普医疗技术有限公司、波士顿科学公司、Oscor 公司、Osypca Medical GmbH、Zoll Medical Corporation、微创医疗科学公司、库克集团公司、索林集团、Vitatron & Medical Co.、Cordis 公司、Shree Puptronix Limited、Medico SpA、圣塔尼亚Devices、Cardiostim、Advena Ltd.、Mediana Co.Ltd.、Vimecon GmbH、Cardiac Science Corporation、Greatbatch Medical、Galix Biomedical Instrumentation、南京微创医疗、Cardionovum GmbH。

2024年，北美是心臟节律器市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。心臟节律器市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

心臟节律器市场报告涉及的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

心臟起搏器市场包括单腔、双腔和双心室起搏器的销售。该市场的价值指的是“出厂价”，即产品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场的产品价值还包括产品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球心臟节律器：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球心臟节律器市场：成长率分析
  • 全球心臟节律器市场表现：规模与成长，2019-2024
  • 全球心臟节律器市场预测：规模与成长，2024-2029年，2034年
  • 全球心臟节律器：总潜在市场（TAM）

第六章 市场细分

  • 全球心臟节律器市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 嵌入式
  • 外部的
  • 全球心臟节律器市场：按技术、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 两个房间
  • 单人房
  • 双腔
  • 全球心臟节律器市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 心律不整
  • 心臟阻塞
  • 心房颤动
  • 长QT症候群
  • 郁血性心臟衰竭衰竭
  • 其他用途
  • 全球心臟节律器市场：按最终用户、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 诊所和医院
  • 门诊手术中心
  • 心臟护理中心
  • 全球心臟节律器市场：按植入类型细分、实际结果及预测（2019-2024 年、2024-2029 年、2034 年）
  • 单腔起搏器
  • 双腔起搏器
  • 双心室节律器（CRT-P）
  • 无导线起搏器
  • 全球心臟节律器市场：按外部、类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 经皮起搏器
  • 经静脉起搏器

第七章 区域和国家分析

  • 全球心臟节律器市场：区域表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球心臟节律器市场：依国家/地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 心臟节律器市场：竞争格局
  • 心臟起搏器市场：公司简介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Lepu Medical Technology Co. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Oscor Inc.
  • Osypca Medical GmbH
  • Zoll Medical Corporation
  • MicroPort Scientific Corporation
  • Cook Group Incorporated
  • Sorin Group
  • Vitatron & Medical Co.
  • Cordis Inc.
  • Shree Pacetronix Limited
  • Medico SpA
  • St. Jude Medical
  • LivaNova PLC
  • Schiller AG
  • BTL Industries Inc.
  • CCC Medical Devices

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年心臟节律器市场：提供新机会的国家
  • 2029年心臟节律器市场：细分市场带来新机会
  • 2029年心臟节律器市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r21192u

The cardiac pacemaker is defined by small electronic devices that generate electrical impulses to regulate heartbeats and treat conditions like arrhythmias. These devices play a crucial role in preventing the heart from beating too fast or too slow.

The primary categories of cardiac pacemakers consist of implantable and external variants. Implantable cardiac pacemakers, installed through surgery, are electronic devices generating electrical impulses within the chest to maintain a regular heart rate. Different technologies in cardiac pacemakers encompass biventricular, single-chambered, and dual-chambered systems. These devices find applications in treating various conditions such as arrhythmias, heart blockage, atrial fibrillation, long QT syndrome, and congestive cardiac failure. Cardiac pacemakers serve end-users including clinics, hospitals, ambulatory surgical centers, and cardiac care centers. The market continues to evolve with ongoing advancements in technology and surgical procedures, contributing to improved patient care and outcomes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The cardiac pacemakers market research report is one of a series of new reports from The Business Research Company that provides cardiac pacemakers market statistics, including cardiac pacemakers industry global market size, regional shares, competitors with a cardiac pacemakers market share, detailed cardiac pacemakers market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac pacemakers industry. This cardiac pacemakers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac pacemakers market size has grown steadily in recent years. It will grow from $4.73 billion in 2024 to $4.95 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to aging population and the prevalence of cardiovascular diseases, growing awareness of arrhythmias and the need for treatment, investment in research and development for pacemaker innovation, evolving healthcare infrastructure and access to medical devices, and regulatory approvals for novel pacemaker features and technologies.

The cardiac pacemakers market size is expected to see strong growth in the next few years. It will grow to $6.5 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to focus on lead durability and reduction of complications, remote programming and telehealth services for pacemaker patients, expansion of emerging markets and rising healthcare expenditure, enhanced battery technologies for longer pacemaker lifespans, and regulatory support for expedited pacemaker approvals. Major trends in the forecast period include electrophysiology advancements for precision implantation, integration of pacemaker data into electronic health records (ehrs), integration of artificial intelligence (ai) for predictive pacemaker maintenance, advancements in pacemaker technology, including miniaturization, and telemedicine and remote monitoring.

The forecast of 7.1% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for lithium-iodine battery cells and hermetic titanium casings, sourced from key regions such as China and Mexico, which could lead to implantation procedure delays and increased costs for bradycardia treatment.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The surge in cardiovascular diseases is a significant driver for the cardiac pacemaker market. Cardiovascular diseases encompass a range of disorders affecting the heart or blood vessels, including arrhythmias, aorta disease, congenital heart disease, and heart attacks. To address the growing global health concern, cardiac pacemakers, which generate electric activity, are employed in treating patients with cardiovascular diseases. In September 2023, the World Health Organization reported that annually, 41 million deaths, accounting for 74% of non-communicable diseases, were attributed to cardiovascular diseases, highlighting the pressing need for advancements in cardiac care. Consequently, the increasing prevalence of cardiovascular diseases is expected to propel the growth of the cardiac pacemaker market.

Government initiatives aimed at fostering research and development in healthcare are poised to drive the cardiac pacemaker market. These initiatives, undertaken by government authorities at various levels, encompass actions, programs, and policies designed to address healthcare challenges and promote positive societal changes. Notably, in 2022, the UK government allocated £260 million ($270.65 million) in funding to bolster healthcare research and manufacturing. This commitment, from the Department of Health and Social Care, supports NHS-led health research into diagnostics and treatments, with a focus on enhancing clinical research services. Additionally, £60 million ($63.60 million) was earmarked to expand life sciences manufacturing in the UK. Such government initiatives play a pivotal role in advancing cardiac care and fueling the growth of the cardiac pacemaker market.

Innovations, particularly the development of leadless cardiac pacemakers, emerge as a key trend in the cardiac pacemaker market. Major players in the industry are actively introducing innovative solutions to enhance patient care and market competitiveness. The leadless pacemaker, a self-contained generator and electrode system, offers significant advantages, being 90% smaller than traditional transvenous pacemakers. Its implantation via a femoral vein transcatheter technique eliminates the need for chest incisions and subcutaneous generator pockets. Notably, in January 2022, Medtronic PLC, an Ireland-based medical devices company, introduced the Micra AV Transcatheter Pacing System (TPS), a leadless pacemaker designed for patients with compromised electrical communication between the heart's ventricle and atria, addressing a critical aspect of cardiac health with cutting-edge technology.

Major companies in the cardiac pacemaker market are innovating products such as i2i communication technology, which facilitates real-time communication between two devices. This i2i (infrastructure-to-infrastructure) communication technology allows seamless data exchange between different infrastructure systems, enhancing automation and operational efficiency. For example, in November 2023, Abbott Laboratories, a US-based medical device company, launched the AVEIR DR System to treat patients with abnormal or slow heart rhythms. This cutting-edge dual-chamber leadless pacemaker system provides synchronized pacing for both the right atrium and ventricle, ensuring a proper heart rhythm. It is implanted using a minimally invasive procedure, which decreases recovery time and complications. The advanced implant-to-implant technology enables real-time communication between the devices, coordinating effective pacing. This innovation marks a significant advancement in heart health management.

In July 2022, Orchestra BioMed, a US-based company specializing in transformative therapeutic products, entered into a collaboration with Medtronic. The partnership between Medtronic and Orchestra BioMed aims to develop BackBeat Cardiac Neuromodulation Therapy (CNT), a potential therapeutic solution for hypertension in individuals requiring a cardiac pacemaker. This collaboration underscores the commitment of major players, such as Medtronic, to pioneer advancements in healthcare technology and contribute to the evolution of cardiac care.

Major companies operating in the cardiac pacemakers market include Medtronic plc, Lepu Medical Technology Co., Abbott Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, Oscor Inc., Osypca Medical GmbH, Zoll Medical Corporation, MicroPort Scientific Corporation, Cook Group Incorporated, Sorin Group, Vitatron & Medical Co., Cordis Inc., Shree Pacetronix Limited, Medico SpA, St. Jude Medical, LivaNova PLC, Schiller AG, BTL Industries Inc., CCC Medical Devices, Cardiostim, Advena Ltd., Mediana Co. Ltd., Vimecon GmbH, Cardiac Science Corporation, Greatbatch Medical, Galix Biomedical Instrumentation, Nanjing MicroPort Medical, Cardionovum GmbH

North America was the largest region in the cardiac pacemakers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac pacemakers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the cardiac pacemakers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The cardiac pacemaker market consists of sales of single chamber, dual chamber and Biventricular pacemakers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Pacemakers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac pacemakers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac pacemakers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac pacemakers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Implantable; External
  • 2) By Technology: Biventricular; Single Chambered; Dual Chambered
  • 3) By Application: Arrhythmias; Heart Blockage; Atrial Fibrillation; Long QT Syndrome; Congestive Cardiac Failure; Other Applications
  • 4) By End User: Clinics And Hospitals; Ambulatory Surgical Centers; Cardiac Care Centers
  • Subsegments:
  • 1) By Implantable: Single Chamber Pacemakers; Dual Chamber Pacemakers; Biventricular Pacemakers (CRT-P); Leadless Pacemakers
  • 2) By External: Transcutaneous Pacemakers; Transvenous Pacemakers
  • Companies Mentioned: Medtronic plc; Lepu Medical Technology Co.; Abbott Inc.; Biotronik SE & Co. KG; Boston Scientific Corporation; Oscor Inc.; Osypca Medical GmbH; Zoll Medical Corporation; MicroPort Scientific Corporation; Cook Group Incorporated; Sorin Group; Vitatron & Medical Co.; Cordis Inc.; Shree Pacetronix Limited; Medico SpA; St. Jude Medical; LivaNova PLC; Schiller AG; BTL Industries Inc.; CCC Medical Devices; Cardiostim; Advena Ltd.; Mediana Co. Ltd.; Vimecon GmbH; Cardiac Science Corporation; Greatbatch Medical; Galix Biomedical Instrumentation; Nanjing MicroPort Medical; Cardionovum GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Pacemakers Market Characteristics

3. Cardiac Pacemakers Market Trends And Strategies

4. Cardiac Pacemakers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiac Pacemakers Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiac Pacemakers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiac Pacemakers Market Growth Rate Analysis
  • 5.4. Global Cardiac Pacemakers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiac Pacemakers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiac Pacemakers Total Addressable Market (TAM)

6. Cardiac Pacemakers Market Segmentation

  • 6.1. Global Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable
  • External
  • 6.2. Global Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biventricular
  • Single Chambered
  • Dual Chambered
  • 6.3. Global Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Arrhythmias
  • Heart Blockage
  • Atrial Fibrillation
  • Long QT Syndrome
  • Congestive Cardiac Failure
  • Other Applications
  • 6.4. Global Cardiac Pacemakers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinics And Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Care Centers
  • 6.5. Global Cardiac Pacemakers Market, Sub-Segmentation Of Implantable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Chamber Pacemakers
  • Dual Chamber Pacemakers
  • Biventricular Pacemakers (CRT-P)
  • Leadless Pacemakers
  • 6.6. Global Cardiac Pacemakers Market, Sub-Segmentation Of External, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcutaneous Pacemakers
  • Transvenous Pacemakers

7. Cardiac Pacemakers Market Regional And Country Analysis

  • 7.1. Global Cardiac Pacemakers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiac Pacemakers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Pacemakers Market

  • 8.1. Asia-Pacific Cardiac Pacemakers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Pacemakers Market

  • 9.1. China Cardiac Pacemakers Market Overview
  • 9.2. China Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Pacemakers Market

  • 10.1. India Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Pacemakers Market

  • 11.1. Japan Cardiac Pacemakers Market Overview
  • 11.2. Japan Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Pacemakers Market

  • 12.1. Australia Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Pacemakers Market

  • 13.1. Indonesia Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Pacemakers Market

  • 14.1. South Korea Cardiac Pacemakers Market Overview
  • 14.2. South Korea Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Pacemakers Market

  • 15.1. Western Europe Cardiac Pacemakers Market Overview
  • 15.2. Western Europe Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Pacemakers Market

  • 16.1. UK Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Pacemakers Market

  • 17.1. Germany Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Pacemakers Market

  • 18.1. France Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Pacemakers Market

  • 19.1. Italy Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Pacemakers Market

  • 20.1. Spain Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Pacemakers Market

  • 21.1. Eastern Europe Cardiac Pacemakers Market Overview
  • 21.2. Eastern Europe Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Pacemakers Market

  • 22.1. Russia Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Pacemakers Market

  • 23.1. North America Cardiac Pacemakers Market Overview
  • 23.2. North America Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Pacemakers Market

  • 24.1. USA Cardiac Pacemakers Market Overview
  • 24.2. USA Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Pacemakers Market

  • 25.1. Canada Cardiac Pacemakers Market Overview
  • 25.2. Canada Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Pacemakers Market

  • 26.1. South America Cardiac Pacemakers Market Overview
  • 26.2. South America Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Pacemakers Market

  • 27.1. Brazil Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Pacemakers Market

  • 28.1. Middle East Cardiac Pacemakers Market Overview
  • 28.2. Middle East Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Pacemakers Market

  • 29.1. Africa Cardiac Pacemakers Market Overview
  • 29.2. Africa Cardiac Pacemakers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiac Pacemakers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiac Pacemakers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Pacemakers Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac Pacemakers Market Competitive Landscape
  • 30.2. Cardiac Pacemakers Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Lepu Medical Technology Co. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Pacemakers Market Other Major And Innovative Companies

  • 31.1. Oscor Inc.
  • 31.2. Osypca Medical GmbH
  • 31.3. Zoll Medical Corporation
  • 31.4. MicroPort Scientific Corporation
  • 31.5. Cook Group Incorporated
  • 31.6. Sorin Group
  • 31.7. Vitatron & Medical Co.
  • 31.8. Cordis Inc.
  • 31.9. Shree Pacetronix Limited
  • 31.10. Medico SpA
  • 31.11. St. Jude Medical
  • 31.12. LivaNova PLC
  • 31.13. Schiller AG
  • 31.14. BTL Industries Inc.
  • 31.15. CCC Medical Devices

32. Global Cardiac Pacemakers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Pacemakers Market

34. Recent Developments In The Cardiac Pacemakers Market

35. Cardiac Pacemakers Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiac Pacemakers Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiac Pacemakers Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiac Pacemakers Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer